Cargando…
诱导化疗联合或不联合自体造血干细胞移植治疗年龄≤60岁初治中高危/高危弥漫大B细胞淋巴瘤的比较研究
OBJECTIVE: To compare the efficacy of induction chemotherapy with or without autologous hematopoietic stem cell transplantation (auto-HSCT) for newly diagnosed young diffuse large B cell lymphoma (DLBCL) patients. METHODS: The retrospective study was performed in 90 cases of young patients (≤60 year...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342668/ https://www.ncbi.nlm.nih.gov/pubmed/30831626 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.02.005 |
Ejemplares similares
-
不同异基因造血干细胞移植方式治疗167例中高危骨髓增生异常综合征疗效比较
Publicado: (2017) -
自体和异基因造血干细胞移植治疗60例高危外周T细胞淋巴瘤患者的疗效比较
Publicado: (2016) -
清髓剂量预处理异基因造血干细胞移植治疗年龄≥55岁高危恶性血液系统疾病12例临床分析
Publicado: (2016) -
增强剂量免疫化疗联合一线自体外周血造血干细胞移植治疗年轻、高危侵袭性B细胞淋巴瘤疗效及预后因素分析
Publicado: (2022) -
CAR-T细胞联合PD-1单抗治疗高危慢性淋巴细胞白血病合并Richter转化2例报告并文献复习
Publicado: (2023)